Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Oracle
ORCL
|
+$881M |
| 2 |
DoorDash
DASH
|
+$403M |
| 3 |
Amgen
AMGN
|
+$403M |
| 4 |
Amazon
AMZN
|
+$282M |
| 5 |
Applied Materials
AMAT
|
+$231M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$592M |
| 2 |
Workday
WDAY
|
+$580M |
| 3 |
United Parcel Service
UPS
|
+$468M |
| 4 |
Apple
AAPL
|
+$438M |
| 5 |
Atlassian
TEAM
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.97% |
| 2 | Healthcare | 19.05% |
| 3 | Consumer Discretionary | 10.13% |
| 4 | Financials | 9.7% |
| 5 | Industrials | 9.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2351
Garrett Motion
GTX
$5.37B
| $231K | ﹤0.01% |
23,240
-175
| -0.7% | -$1.61K |
|
2352
Xperi
XPER
$364M
| $230K | ﹤0.01% |
19,104
+4
| +0% | +$44 |
|
|
ACRE
2353
Ares Commercial Real Estate
ACRE
$247M
| $230K | ﹤0.01% |
30,896
+2
| +0% | +$17 |
|
2354
nLIGHT
LASR
$3.33B
| $230K | ﹤0.01% |
17,707
+2
| +0% | +$26 |
|
2355
Midland States Bancorp
MSBI
$697M
| $229K | ﹤0.01% |
9,140
-13,121
| -59% | -$331K |
|
2356
CEVA Inc
CEVA
$831M
| $229K | ﹤0.01% |
10,088
| – | – |
|
2357
Haverty Furniture Companies
HVT
$418M
| $229K | ﹤0.01% |
6,685
-1
| -0% | -$34 |
|
|
XRN
2358
Chiron Real Estate Inc
XRN
$535M
| $228K | ﹤0.01% |
5,230
+1
| +0% | +$48 |
|
2359
Republic Bancorp
RBCAA
$1.96B
| $228K | ﹤0.01% |
4,492
-1
| -0% | -$50 |
|
2360
Liberty Global Class C
LBTYK
$3.5B
| $227K | ﹤0.01% |
12,878
| – | – |
|
2361
LSI Industries
LYTS
$834M
| $227K | ﹤0.01% |
15,032
-10
| -0.1% | -$141 |
|
2362
Stagwell
STGW
$2B
| $227K | ﹤0.01% |
36,531
+6
| +0% | +$38 |
|
2363
Vitesse Energy
VTS
$644M
| $227K | ﹤0.01% |
9,558
-12,333
| -56% | -$271K |
|
2364
First Watch Restaurant Group
FWRG
$814M
| $226K | ﹤0.01% |
+9,196
| New | +$208K |
|
2365
Editas Medicine
EDIT
$399M
| $226K | ﹤0.01% |
30,527
+3
| +0% | +$25 |
|
|
HONE
2366
DELISTED
HarborOne Bancorp
HONE
| $224K | ﹤0.01% |
21,098
-1
| -0% | -$11 |
|
|
FPI
2367
Farmland Partners
FPI
$415M
| $224K | ﹤0.01% |
20,230
+1
| +0% | +$11 |
|
2368
Theravance Biopharma
TBPH
$873M
| $223K | ﹤0.01% |
24,903
+6
| +0% | +$56 |
|
2369
RCI Hospitality Holdings
RICK
$202M
| $223K | ﹤0.01% |
3,846
-1
| -0% | -$59 |
|
2370
ARS Pharmaceuticals
SPRY
$579M
| $223K | ﹤0.01% |
21,813
+4
| +0% | +$30 |
|
|
SWI
2371
DELISTED
SolarWinds Corporation Common Stock
SWI
| $223K | ﹤0.01% |
17,647
+62
| +0.4% | +$755 |
|
2372
i3 Verticals
IIIV
$419M
| $223K | ﹤0.01% |
9,731
+1
| +0% | +$21 |
|
2373
Manitowoc
MTW
$491M
| $222K | ﹤0.01% |
15,722
+1
| +0% | +$15 |
|
|
SMMF
2374
DELISTED
Summit Financial Group, Inc.
SMMF
| $222K | ﹤0.01% |
8,168
-844
| -9% | -$23.2K |
|
2375
Allient
ALNT
$1.34B
| $222K | ﹤0.01% |
+6,224
| New | +$186K |
|
Similar funds
Janus Henderson Group's Q1 2024 Portfolio in Review
As of Q1 2024, Janus Henderson Group held 2,613 positions worth $183B, up 9.3% from $168B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Janus Henderson Group's Q1 2024 filing shows 67 new, 1,353 increased, 903 reduced and 85 closed positions. Its largest new stake was CG Oncology: 1,521,432 shares worth $66.8M. The largest sale was Abbott, an estimated $592M.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 33% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q1 2024 buy was CG Oncology: 1,521,432 shares worth $66.8M.
- Janus Henderson Group added most to Oracle in Q1 2024, an estimated $881M increase.
- Janus Henderson Group's biggest Q1 2024 reduction was Abbott, cutting an estimated $592M.
- Janus Henderson Group fully exited Immunogen Inc in Q1 2024, selling an estimated $327M.
- Janus Henderson Group's ten largest holdings make up 28% of its $183B portfolio in Q1 2024.
- Janus Henderson Group opened 67 new positions and closed 85 in Q1 2024.
- Janus Henderson Group's portfolio value rose 9.3% quarter-over-quarter to $183B.
Based on Janus Henderson Group's 13F filing for Q1 2024, filed 15 May 2024.